Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

According to doctors, making a misstep is easier than you may think.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...

Ozempic, Wegovy and similar medications can drive dramatic weight loss, but doctors warn they’re not lifestyle shortcuts—and stopping them may come with serious consequences.

The desire for smaller portions and fewer junk foods is affecting what the food industry is selling us.

At Lifesum, we help organizations like Amazon, PayPal and GE, turn appetite changes into lasting habits through personalized ...

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

Langers is working on making the No Worries GLP-1 support beverage available through both online and retail locations. It’s already available via Amazon.com, and Langer said the Texas-based Spec’s ...

Losing weight is best done with medical supervision.

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of ...

Several new products promise to reverse weight loss-induced sagging.

GLP‑1 weight‑loss drugs are reshaping food and drink manufacturing, driving demand for portion‑smart meals, high‑protein ...